The susceptibility of the brain to ischaemic injury dramatically limits its viability following
interruptions in blood flow. However, data from studies of dissociated cells, tissue …

Xenon is a rare noble gas that was introduced into clinical practice more than 70 years ago.
Xenon's clinical properties are predicated by its ability to fit into preformed cavities of …

In recent years, inert gases such as helium, argon, and xenon have gained considerable
attention for their medical value. Noble gases present an intriguing scientific paradox …

Cardiac arrest (CA) results in global ischemia-reperfusion injury damaging tissues in the
whole body. The landscape of therapeutic interventions in resuscitation medicine has …

Cardiocerebrovascular diseases (CCVDs) are the leading cause of death worldwide;
therefore, to deeply explore the pathogenesis of CCVDs and to find the cheap and efficient …

Stroke is deemed a worldwide leading cause of neurological disability and death, however,
there is currently no promising pharmacotherapy for acute ischemic stroke aside from …

Background The noble gases argon and xenon are potential novel neuroprotective
treatments for acquired brain injuries. Xenon has already undergone early-stage clinical …

The growth of the elderly population has led to an increase in patients with myocardial
infarction and stroke (Wajngarten and Silva, Eur Cardiol 14: 111–115, 2019). Patients …

Background Xenon has profound neuroprotective effects after neurological injury and is
currently undergoing phase 2 clinical trials in cardiac arrest patients. However, xenon is very …

Objectives: Preclinical studies reveal the neuroprotective properties of xenon, especially
when combined with hypothermia. The purpose of this study was to investigate the feasibility …